Althera Laboratories Reinforces Commitment to Emerging Markets with Presence at CPHI South East Asia 2025

June 23, 2025 09:24 PM AEST | By EIN Presswire

Google News:

Recent News

GP Cellulose Merges Innovation With Responsibility - Utilizing Advance...

Alcoa Schedules Second Quarter 2025 Earnings Release and Conference Ca...

From Refugee to Farmer: Uganda’s Model for Empowering Displaced Commun...

'Luke' by Tahan Music Co. - A Lovable Country Summer Anthem about Frie...

DUBLIN, DUBLIN, IRELAND, June 23, 2025 /EINPresswire.com/ -- Althera Laboratories, a pharmaceutical company focused on developing value-added medicines for cardiovascular and metabolic diseases, today announced it will be exhibiting at CPHI South East Asia. The premier regional pharmaceutical event will take place from July 16th to 18th, 2025, at Malaysia International Trade and Exhibition Centre (MITEC), Kuala Lumpur, Malaysia.

Althera Laboratories will welcome industry leaders and potential partners at its own dedicated exhibit at Booth N16. This significant presence underscores the company's deep commitment to expanding into key emerging markets and addressing the growing prevalence of cardiovascular and metabolic diseases in the South East Asia region.

This strategic move aligns with Althera's core mission to improve global access to its pipeline of innovative fixed-dose combinations. The company will showcase its portfolio of value-added medicines and discuss licensing opportunities for its advanced cardiovascular therapies, including its recently unveiled triple-combination candidates for heart failure. Attending CPHI South East Asia provides a direct platform to forge the strategic partnerships necessary to bring these superior therapeutic options to patients in the region.

"Our presence at CPHI South East Asia is a clear statement of our intent to become a key partner in the region's healthcare ecosystem," said Mathieu Da Luz, Business Development Director at Althera Laboratories. "South East Asia is a vital territory in the global effort to manage cardiovascular and metabolic diseases. By establishing a strong presence at this crucial event, we are actively seeking collaborators who share our vision of providing effective, convenient, and accessible treatments. We invite attendees to visit our booth to explore how our innovative pipeline can create mutual, long-term value."

Professionals attending CPHI South East Asia are encouraged to visit Booth N16 at the Kuala Lumpur Convention Centre to meet with the Althera Laboratories team and learn more about their portfolio and partnership opportunities.

Da Luz Mathieu
Althera Laboratories
email us here
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.